Soluble triggering receptor expressed on myeloid cells 2 (sTREM2) concentration is increased in cerebrospinal fluid (CSF) in early symptomatic phase of Alzheimer’s disease (AD). The gene discussed is TREM2; the disease is early-onset autosomal dominant Alzheimer disease.